Influence of diabetes on norepinephrine-induced inositol 1,4,5-trisphosphate levels in rat aorta

Worku Abebe, Kathleen M. MacLeod

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Abstract

The effects of norepinephrine on total tissue levels of inositol 1,4,5-triphosphate were measured by protein binding assay in aortas from rats with chronic streptozotocin-induced diabetes and from age-matched control rats. In both control and diabetic aortas, norepinephrine induced a rapid, transient and concentration-dependent elevation of inositol 1,4,5-trisphosphate content during contraction. Maximum production of inositol 1,4,5-trisphosphate in response to norepinephrine was greater in diabetic than in control aortas. However, the sensitivities of control and diabetic aortas to norepinephrine for inositol 1,4,5-trisphosphate production were not significantly different. Enhanced norepinephrine-induced production of inositol 1,4,5-trisphosphate in diabetic aortas may contribute to the increased maximum contractile responsiveness of these arteries to the agonist. However, since enhanced contractile responses of diabetic aortas to norepinephrine were also detected at times when inositol 1,4,5-trisphosphate levels were not significantly increased, other factors also appear to be involved in mediating enhanced contractions of diabetic arteries to norepinephrine.

Original languageEnglish (US)
Pages (from-to)PL85-PL90
JournalLife sciences
Volume49
Issue number13
DOIs
StatePublished - 1991
Externally publishedYes

ASJC Scopus subject areas

  • General Pharmacology, Toxicology and Pharmaceutics
  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Influence of diabetes on norepinephrine-induced inositol 1,4,5-trisphosphate levels in rat aorta'. Together they form a unique fingerprint.

Cite this